Akebia Therapeutics | AKBA - Ebit





Ebit Veränderung Datum
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.83B 130M 2026-03
Ardelyx USD 5.1M 2.02M 2025-12
Astellas Pharma JPY 48.57B 85.97B 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bayer EUR 1.11B 1.51B 2025-12
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 6.62B 1.51B 2026-03
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Moderna USD -1.39B 531M 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pharma Mar EUR 622K 42.99M 2026-03
Prothena USD -27.21M 12.55M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Qiagen NV USD 121.88M 19.18M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Sartorius EUR 160.7M 94.1M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -21.52M 374K 2025-12
Tilray USD -20.01M 9.34M 2025-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03